MENU
Most screening problems start upstream, before screening begins.
When patients reach sites too early, it can lead to:
screening waste
site burden
slower enrollment
manual triage
patient drop-off
But Antidote helps improve referral quality through stronger prescreening, patient-centric outreach, partner-based recruitment, and site follow-up.
What You’ll Learn
Why volume alone does not fix screening waste
What causes referral failure upstream
How stronger prescreening improves referral quality
Why patient-centric recruitment supports better progression
What Antidote’s case studies reveal
Antidote’s Proof Points
6 months saved in a UK asthma study
267% of goal in a US Alzheimer’s study
178% of goal in a global psoriasis study
23 randomizations at a 72% rate in presbyopia
80 randomizations at a 96% rate in cardiovascular
Explore Antidote’s Referral-Quality Model